PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
64.06
Similar ESG score to RVPH's 63.02. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
59.39
Environmental score 80-90% of RVPH's 70.36. Walter Schloss would scrutinize carbon exposure and transition planning.
65.71
Social score exceeding 1.2x RVPH's 54.02. Mohnish Pabrai would examine if this social advantage creates sustainable talent and customer acquisition advantages.
67.07
Similar governance score to RVPH's 64.69. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.